Envista Holdings Corporation (NYSE: NVST) (“Envista”) has announced its participation in the J.P. Morgan Healthcare Conference on Monday, January 8, 2024, from 3:00 to 3:40 PM PST. An audio-only recording link will be available on Envista’s investor relations website for up to 30 days post-event.
About Envista Holdings Corporation
Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services.
Its comprehensive portfolio, covering dental implants and treatment options, orthodontics, and digital imaging technologies, addresses a wide array of dentists’ clinical needs for diagnosing, treating, and preventing dental conditions, as well as improving the aesthetics of the human smile.
With a foundation comprised of the proven Envista Business System (EBS) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus, Envista is well-equipped to meet the end-to-end needs of dental professionals worldwide. Envista is one of the largest global dental products companies, with significant market positions in some of the most attractive segments of the dental products industry.
For more information, please visit www.envistaco.com.
